Selection of protein targets with validated assays
Protein target binding domains vary, and so do the types of interactions the AI system needs to learn to succeed for any given target. The Enlace Bio virtual screening has been validated retrospectively across a range of different protein targets, and below is a selection of these. Contact us to discuss your protein target of interest.
NTRK3
Class: Enzyme – Kinase
Uniprot ID: Q16288
Therapy area: Oncology
Sensitivity: 88%
Specificity: 90%
ATAD2
Class: Epigenetic regulator
Uniprot ID: Q6PL18
Therapy area: Oncology
Sensitivity: 95%
Specificity: 83%
CFD
Class: Enzyme – Protease
Uniprot ID: P00746
Therapy area: Immunology
Sensitivity: 97%
Specificity: 78%
PKMYT1
Class: Enzyme – Kinase
Uniprot ID: Q99640
Therapy area: Oncology
Sensitivity: 68%
Specificity: 86%
HSP90AB1
Class: Molecular Chaperone
Uniprot ID: P08238
Therapy area: Oncology
Sensitivity: 79%
Specificity: 78%
Sensitivity measures the virtual screening’s ability to correctly identify high affinity compounds (<10 μM) and specificity measures its ability to correctly identify low affinity/non-binding compounds. The targets were validated retrospectively by comparing the AI system's ranking of affinity strength of compounds, compared to experimentally determined values. Experimental assays from 2022 onwards were included when calculating the metrics, and the system has only been trained or evaluated on data up to 2021 during development.